Supporting the Fight: The Role of Community Pharmacy in Oncology Care

1. Review oncology diagnoses commonly encountered in community pharmacy settings.
2. Discuss commonly prescribed oncology medications and oncology-related therapies, along with their associated side effects.
3. Describe strategies for managing medication-related adverse effects in oncology patients.
4. Identify the pharmacist’s role in providing education and support to oncology patients and their caregivers.
5. Develop a supportive care plan that addresses side effect management, medication adherence, and patient counseling needs.

Technician Learning Objectives

1. Identify common oncology diagnoses relevant to community pharmacy practice.
2. List commonly dispensed oncology medications and oncology-related therapies, along with their formulations.
3. Explain the importance of accurate inventory management for medications related to oncology care.
4. Discuss the technician’s role in supporting pharmacists and patients with oncology treatment plans.
5. Develop a supportive care plan in collaboration with a pharmacist that addresses side effect management, medication adherence, and patient counseling needs.

Meet Your Speaker

Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, FAPO
Director of Pharmacy
Minnesota Oncology

Dr. Hanna is board certified by the Board of Pharmacy Specialties in Oncology Pharmacy and Pharmacotherapy. He received his Doctorate of Pharmacy from Florida A&M University, completed his general residency at St. Thomas Hospital, Nashville, TN and his oncology residency at St. Luke’s Mountain States Tumor Institute, Boise, ID. He is currently the Director of Pharmacy at Minnesota Oncology and an Assistant Professor of Pharmacy at the Mayo Clinic College of Medicine. Dr. Hanna serves as an Associate Editor for the Journal of the Advanced Practitioner in Oncology (JADPRO). Dr. Hanna’s research interests are focused on B-cell malignancies and genitourinary cancers. He is a recognized Fellow of the Association of Community Cancer Centers (ACCC) and the Advanced Practitioner Society for Hematology/Oncology (APSHO). Dr. Hanna is a Board member of the National Community Oncology Dispensing Association (NCODA).

Kirollos Hanna has no relevant financial relationships with ineligible companies to disclose.

Financial support for this course was provided through an educational grant from McKesson Health Mart.